← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 2, 2017Last known activity
Oct 28, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 4 trials)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (8)
- NCT06717685Sponsor investigatorPhase 3Oct 28, 2024
- NCT06717685Lead sponsorPhase 3Oct 28, 2024
- NCT05744752Lead sponsorN/ADec 19, 2022
- NCT05744752Sponsor investigatorN/ADec 19, 2022
- NCT04204044Overall official - principal investigatorEarly Phase 1Jan 1, 2020
- NCT04204044Lead sponsorEarly Phase 1Jan 1, 2020
- NCT04204044Reponsible party - principal investigatorEarly Phase 1Jan 1, 2020
- NCT04650763Study directorN/AOct 2, 2017
Details
- Last known activity
- Oct 28, 2024